/PRNewswire/ Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), today announced that the Company has been added to the Hong Kong.
Brii Biosciences Joins Hang Seng Composite Index prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Brii Biosciences Joins Hang Seng Composite Index prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Data supporting the EUA filing will be submitted to the FDA on a rolling basis with the ultimate goal of securing regulatory approval as soon as possible Submission is based on positive Phase 3 data from the NIH-sponsored ACTIV-2 study, which demonstrated a statistically significant reduction of hospitalization and death over placebo in COVID-19 outpatients treated within an early.